CX797

CAS No. 1611496-70-8

CX797( CX-797 | CX 797 )

Catalog No. M12334 CAS No. 1611496-70-8

A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CX797
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.
  • Description
    A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM; inhibits IL8-mediated cAMP signaling and receptor degradation while specifically up-regulating IL8-mediated β-arrestin-2 recruitment; also inhibits IL8-mediated cell migration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CX-797 | CX 797
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1611496-70-8
  • Formula Weight
    382.5
  • Molecular Formula
    C19H18N4OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1CCCC2=C1C3=C(S2)N4C(=NN=C4SC)N(C3=O)C5=CC=CC=C5
  • Chemical Name
    (R)-6-methyl-1-(methylthio)-4-phenyl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ha H, et al. Mol Pharm. 2014 Jul 7;11(7):2431-41.
molnova catalog
related products
  • MK-0812

    A potent CCR2 specific antagonist that blocks MCP-1 mediated response with an IC50 of 3.2 nM.

  • POL3026

    A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.2 nM in Ca2+ flux assay.

  • (R)-CCX-777

    A small-molecule partial agonist of CXCR7 (ACKR3).